SCHEMBL901922

SCHEMBL901922

COC(=O)c1ccc(Nc2cc(Br)nc(Nc3cc(C(F)(F)F)ccn3)c2)cc1

nearest known ligand 0.45

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
ROCK1 Q13464 1/20 0.45
SYK P43405 9/20 0.44
IDH2 P48735 1/20 0.42
KDR P35968 1/20 0.42
MAP3K12 Q12852 2/20 0.41
KDM4E B2RXH2 1/20 0.40
MEN1 O00255 1/20 0.40
HPGD P15428 1/20 0.40
KMT2A Q03164 1/20 0.40
RXFP1 Q9HBX9 1/20 0.40
AURKA O14965 2/20 0.40
ALDH1A1 P00352 1/20 0.40
GAA P10253 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
P2RY1 P47900 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13823683 0.81 IDH2 (0.49) SYKIDH2MAP3K12KDM4EALDH1A1
SCHEMBL901918 0.77 KMT2A (0.59) ROCK1KDM4EMEN1HPGDKMT2A
SCHEMBL17536757 0.76 SYK (0.45) SYKIDH2KDRMAP3K12KDM4E
SCHEMBL15819813 0.75 SYK (0.47) SYKIDH2MAP3K12ALDH1A1GAA
SCHEMBL28994210 0.74 BTK (0.57) KDRKDM4EMEN1KMT2AALDH1A1
SCHEMBL13726067 0.74 SYK (0.62) SYKIDH2MAP3K12
SCHEMBL12893944 0.73 ROCK1 (0.53) ROCK1KDM4EMEN1HPGDKMT2A
SCHEMBL15829252 0.73 SYK (0.49) SYKIDH2MAP3K12
SCHEMBL24349565 0.72 GPR52 (0.66) ROCK1AURKAP2RY1
SCHEMBL13737619 0.71 NOS3 (0.49) SYKIDH2MAP3K12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2441755-A1 Pyridine- and isoquinoline-derivatives as Syk and JAK kinase inhibitors Almirall, S.A. (ES) 2012-04-18 EP disclosed
WO-2012041476-A1 PYRIDINE AND ISOQUINOLINE DERIVATIVES AS SYK- AND JAK-KINASE INHIBITORS ALMIRALL, S.A. (ES) 2012-04-05 WO disclosed